Literature DB >> 15475208

Viable osteoblastic potential of cortical reamings from intramedullary nailing.

Jan Paul M Frölke1, Jenneke Klein Nulend, Cor M Semeins, Fred C Bakker, Peter Patka, Henk J Th M Haarman.   

Abstract

To analyze the effect of intramedullary reaming on fracture healing, we investigated whether or not cortical reamings contain viable bone cells. There are several tissue components contained in medullary reamings including blood, bone marrow and cortical bone. This study is focused on the cortical reamings, which are produced during reaming of the medullary cavity. They may stimulate fracture healing but it is still unclear if they contain vital bone cells. We tested the hypothesis that these cortical reamings are a source of viable bone cells and compared cell cultures with cultivated cells from iliac crest biopsies. Responses of protein content and ALP activity to vitD stimulation in the cells were considered as properties of viability. Ten in tact living sheep femora were fully reamed and the cortical reamings were cultivated in a standard manner and compared with cultivated cells from ipsi-lateral iliac crest biopsies from the same animals. Cells started to grow from the reamings as well as the iliac crest within 2-5 days, and covered the entire culture flask within 9-13 days. Protein content and ALP activity in cells from both reamings and iliac crest were significantly responsive to vitD stimulation. Cortical reamings from intramedullary nailing have osteoblastic potential and contain living bone cells similar to bone cells from the iliac crest. These findings may further explain the superior healing of fractures, treated with reamed nailing.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15475208     DOI: 10.1016/j.orthres.2004.03.011

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  8 in total

1.  Bone graft harvesting using the RIA (reaming irrigation aspirator) system - a quantitative assessment.

Authors:  Florian M Kovar; Gerald E Wozasek
Journal:  Wien Klin Wochenschr       Date:  2011-04-13       Impact factor: 1.704

2.  [The reamer-irrigator-aspirator (RIA) System].

Authors:  R Pfeifer; P Kobbe; M Knobe; H-C Pape
Journal:  Oper Orthop Traumatol       Date:  2011-12       Impact factor: 1.154

3.  Osteogenic potential of reamer irrigator aspirator (RIA) aspirate collected from patients undergoing hip arthroplasty.

Authors:  Ryan M Porter; Fangjun Liu; Carmencita Pilapil; Oliver B Betz; Mark S Vrahas; Mitchel B Harris; Christopher H Evans
Journal:  J Orthop Res       Date:  2009-01       Impact factor: 3.494

4.  Deformity correction with total knee arthroplasty for severe knee osteoarthritis accompanying extra-articular femoral deformity: the results are promising.

Authors:  B Demir; B Özkul; M S Saygılı; E Çetinkaya; D Akbulut
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2018-04-09       Impact factor: 4.342

5.  The effect of locally delivered recombinant human bone morphogenetic protein-2 with hydroxyapatite/tri-calcium phosphate on the biomechanical properties of bone in diabetes-related osteoporosis.

Authors:  Frank A Liporace; Eric A Breitbart; Richard S Yoon; Erin Doyle; David N Paglia; Sheldon Lin
Journal:  J Orthop Traumatol       Date:  2014-11-25

6.  Reamed interlocking intramedullary nailing for the treatment of tibial diaphyseal fractures and aseptic nonunions. Can we expect an optimum result?

Authors:  Byron E Chalidis; George E Petsatodis; Nick C Sachinis; Christos G Dimitriou; Anastasios G Christodoulou
Journal:  Strategies Trauma Limb Reconstr       Date:  2009-08-25

7.  Nailing treatment in bone transport complications.

Authors:  C Biz; C Iacobellis
Journal:  Strategies Trauma Limb Reconstr       Date:  2014-07-24

8.  Reamed versus unreamed intramedullary nailing for the treatment of femoral fractures: A meta-analysis of prospective randomized controlled trials.

Authors:  A-Bing Li; Wei-Jiang Zhang; Wei-Jun Guo; Xin-Hua Wang; Hai-Ming Jin; You-Ming Zhao
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.